'Global des therapeutics market' presentation slideshows

JSB Market Research: PharmaPoint: Dry Eye Syndrome

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

165 views • 7 slides